Company / Net Debt per Share
NovoCure Ltd Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.94
FY2025
5-year range
-$0.62 / $4.33
FY2021-FY2025
Trend
+250.7%
vs FY2024
Sector context
#72 of 100
Health Care
What the data says
Net Debt per Share changed +251% YoY in FY2025, a notable deviation from the 9-year average annual change of +123%.
Based on SEC 10-K filings.
0.94 in FY2025 with a 5-year CAGR of -13.8%.
Improved from $3.12 to $0.94 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -40.0%
- 5-Year CAGR
- -13.8%
- 10-Year CAGR
- -
Sector benchmark
#29 of 100 in Health CareTop 28% of 100This company $0.94 Sector average $7.44
▼
-87.4% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 250.7% year-over-year.
- Ranks #72 out of 100 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2022.
- Lowest net debt per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.94 | +250.7% |
| FY2024 | -$0.62 | -119.9% |
| FY2023 | $3.12 | -27.9% |
| FY2022 | $4.33 | +25.4% |
| FY2021 | $3.45 | +76.1% |
| FY2020 | $1.96 | +755.7% |
| FY2019 | -$0.30 | -409.6% |
| FY2018 | $0.10 | -55.1% |
| FY2017 | $0.22 | +608.4% |
| FY2016 | -$0.04 | +99.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026